Biofloris Pharmaceuticals Private Limited
About Biofloris Pharmaceuticals Private Limited
Data last updated:
Biofloris Pharmaceuticals Private Limited is a private limited company based in Salem, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U33300TZ2017PTC029531. Its GSTIN is 33AAHCB4660K1ZM (Tamil Nadu).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹57 Lakh. It is led by directors including Premkumar Asokumar and Muthu Chellappan Deivasigamani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D No 28 Town Railway Station Road, Salem Town, Tamil Nadu, India – 636001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.84 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹53.35 Lakh (net margin 9.1%) and EBITDA of ₹83.94 Lakh (EBITDA margin 14.4%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 31% over five years.
As per MCA filings, the company has open charges of ₹63 Lakh on record. The company has 7 deals on record (5 rights issues, 2 secondary share transfers); the latest was in August 2021. Its 10 peer companies in the Pharma industry (Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Donas Drugs and Pharmaceuticals Private Limited with revenue of ₹5.93 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD No 28 Town Railway Station Road, Salem Town, Tamil Nadu, India – 636001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Biofloris Pharmaceuticals Private Limited
The main business activity of Biofloris Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Biofloris Pharmaceuticals Private Limited FY 2025 filings available
Biofloris Pharmaceuticals Private Limited reported revenue of ₹5.84 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Biofloris Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 16% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Biofloris Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹83.94 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹53.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Biofloris Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biofloris Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Biofloris Pharmaceuticals Private Limited
Biofloris Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Donas Drugs and Pharmaceuticals Private Limited | ₹5.93 Cr (FY 2020) | •••• | •••• | -11.0% | •••• | Chennai, Tamil Nadu, India |
| Doleshwor Pharmaceuticals Private Limited | ₹5.93 Cr (FY 2025) | •••• | •••• | -36.0% | •••• | New Delhi, Delhi, India |
| Golden Mist Pharmaceuticals Private Limited | ₹5.92 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Vasai, Maharashtra, India |
| Deepin Pharmaceuticals Private Limited | ₹5.91 Cr (FY 2024) | •••• | •••• | -32.0% | •••• | Madhya Pradesh, India |
| PMC Pharmaceuticals India Private Limited | ₹5.86 Cr (FY 2025) | •••• | •••• | -57.0% | •••• | Kolkata, West Bengal, India |
| Biofloris Pharmaceuticals Private Limited this company | ₹5.84 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Salem, Tamil Nadu, India |
| Race Pharmaceuticals Private Limited | ₹5.82 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Chennai, Tamil Nadu, India |
| Trexgen Pharmaceuticals Private Limited | ₹5.78 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Ahmedabad, Gujarat, India |
| Drakt Pharmaceuticals Pvt Ltd | ₹5.75 Cr (FY 2019) | •••• | •••• | -24.0% | •••• | Kolkata, West Bengal, India |
| D.N. Pharmaceuticals Private Limited | ₹5.75 Cr (FY 2022) | •••• | •••• | 13.0% | •••• | Kanpur Dehat, Uttar Pradesh, India |
| Manomay Pharmaceuticals Private Limited | ₹5.72 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Biofloris Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Biofloris Pharmaceuticals Private Limited
Biofloris Pharmaceuticals Private Limited is audited by SENGOTTAIYAN & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SENGOTTAIYAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Biofloris Pharmaceuticals Private Limited
Biofloris Pharmaceuticals has 9 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Premkumar Asokumar Also directs: Fitura Private Limited | Director | 01 Dec 2017 | 8 Years 10 Months | Current |
| Muthu Chellappan Deivasigamani Also directs: Kongu Association LLP | Director | 01 Dec 2017 | 8 Years 10 Months | Current |
| Balakrishnan Rajaganesan | Director | 01 Dec 2017 | 8 Years 10 Months | Current |
| Subbarayagounder Palaniappan Sathish Kumar | Director | 01 Dec 2017 | 8 Years 10 Months | Current |
| Manickam Rajendran | Director | 01 Dec 2017 | 8 Years 10 Months | Current |
| Arjunan Karthikeyan | Director | 15 Jul 2019 | 7 Years 3 Months | Current |
Ownership and Shareholding of Biofloris Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Biofloris Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2025 | Hdfc Bank Limited | ₹26 Lakh | Open |
| 27 Sep 2024 | Hdfc Bank Limited | ₹37 Lakh | Open |
Total charge records: 2 View all charges
Deals & Funding of Biofloris Pharmaceuticals Private Limited
Biofloris Pharmaceuticals Private Limited has 7 deals on record (5 rights issues, 2 secondary share transfers); the latest was in August 2021.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Rights issue | ₹1 Lakh | Investors: an individual |
| Sep 2020 | Rights issue | ₹1 Lakh | Investors: an individual |
| May 2019 | Rights issue | ₹4 Lakh | Investors: 3 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Dec 2018 | Rights issue | ₹11 Lakh | Investors: 4 individuals |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Biofloris Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Biofloris Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Biofloris Pharmaceuticals Private Limited
Biofloris Pharmaceuticals Private Limited has 25 board changes on record since 2017: 17 appointments and 8 cessations. The latest: Mariappan Sukumar Sampathkumar ceased to be Director on 27 Feb 2023.
18 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Biofloris Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biofloris Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biofloris Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Biofloris Pharmaceuticals Private Limited
Biofloris Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCB4660K1ZM | Tamil Nadu | Active | 11 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biofloris Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biofloris Pharmaceuticals Private Limited
Biofloris Pharmaceuticals is an active private limited company based in Salem, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 September 2017 (9+ years old) and is registered under CIN U33300TZ2017PTC029531.
Biofloris Pharmaceuticals reported revenue of ₹5.84 Cr for FY 2025 (up 16% YoY).
Biofloris Pharmaceuticals has 9 current directors:
- Premkumar Asokumar - Director
- Muthu Chellappan Deivasigamani - Director
- Balakrishnan Rajaganesan - Director
- Subbarayagounder Palaniappan Sathish Kumar - Director
- Manickam Rajendran - Director
- Arjunan Karthikeyan - Director
- Rajamanikkam Kandasamy - Director
- Dhanasekaran Ravishankar - Director
- Murugesan Chandrasekaran - Director
Biofloris Pharmaceuticals reported a net profit of ₹53.35 Lakh (net margin 9.1%) and EBITDA of ₹83.94 Lakh (EBITDA margin 14.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Biofloris Pharmaceuticals is 22% over three years and 31% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Biofloris Pharmaceuticals is 33AAHCB4660K1ZM, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Biofloris Pharmaceuticals is U33300TZ2017PTC029531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biofloris Pharmaceuticals was incorporated on 28 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Coimbatore.
Biofloris Pharmaceuticals has 7 deals on record (5 rights issues, 2 secondary share transfers); the latest was in August 2021.
The peers of Biofloris Pharmaceuticals by revenue are Donas Drugs and Pharmaceuticals Private Limited, Doleshwor Pharmaceuticals Private Limited, Golden Mist Pharmaceuticals Private Limited, Deepin Pharmaceuticals Private Limited, PMC Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Mariappan Sukumar Sampathkumar ceased to be Director on 27 Feb 2023. Palanivelrajan ceased to be Director on 27 Feb 2023. Venkatachalam Nandhakumar ceased to be Director on 27 Feb 2023. Biofloris Pharmaceuticals has 25 board changes on record in total.